HEALTH: Summary of Oct 25, 2026

By · Published on

Illustration of laboratory glassware
AI-generated illustration; does not depict the actual event.

Researchers linked blood proteins to aggressive prostate cancer years before diagnosis, and a weekly injection eased sleep apnoea in two trials. Afghanistan reported new polio cases, Alberta expanded hospital capacity, and San Francisco traced two tuberculosis cases to a club.

Blood proteins linked to aggressive prostate cancer years before diagnosis

Researchers at Oxford Population Health have identified proteins in the blood that were associated with a man’s future risk of prostate cancer, including aggressive forms of the disease, in the largest population-based study of its kind. The team analysed samples from 982 men who later developed prostate cancer and a random group of 1,573 men, measuring more than 6,000 proteins and following participants for around 16 years. The findings appeared in a peer-reviewed urology journal and were presented at a major genetics conference.

Twelve proteins were linked to cancers diagnosed more than 15 years after the sample was taken, among them GZMK, which is made by immune cells that recognise and destroy abnormal cells, suggesting the immune system may hold the disease in check long before diagnosis. Seven proteins were tied to aggressive cancer, with ANKRD1 consistently linked to tumours that spread or proved fatal. The researchers said the proteins are not yet suitable as clinical tests, since most associations were modest and further studies are needed.

The samples came from the European Prospective Investigation into Cancer and Nutrition, a Europe-wide study of diet and chronic disease coordinated by the World Health Organization’s International Agency for Research on Cancer. It enrolled 521,457 healthy adults, mostly aged 35 to 70, at 23 centres in ten countries between 1993 and 1999, and prostate cancer was among the most common cancers recorded among its participants. Cancer Research UK, which part-funded the new work, called prostate cancer one of the biggest cancer killers of men.


Weekly weight-loss injection eases sleep apnoea in two late-stage trials

Retatrutide, an experimental once-weekly weight-loss injection, reduced breathing interruptions during sleep in adults with obesity and moderate-to-severe obstructive sleep apnoea, according to two phase 3 trials published in a leading medical journal. After 80 weeks, all three doses tested cut the number of pauses more than a placebo, both in people without type 2 diabetes and in those with the condition. Participants needed a body mass index of at least 27 and at least 15 breathing pauses per hour of sleep.

At the two higher doses, the drug reduced breathing disruptions by an average of 25 pauses per hour, roughly a 40% fall, compared with 10 fewer pauses on placebo. Between 39% and 52% of participants on higher doses improved to no disease or mild disease without excessive daytime sleepiness, against about 13% on placebo, which could mean some no longer need a CPAP breathing mask. People with diabetes on the drug lost an average of 18% to 19% of their body weight, compared with about 6% on placebo.

Retatrutide, developed by Eli Lilly, acts on three hormone receptors, GLP-1, GIP and glucagon, whereas semaglutide and tirzepatide target one and two respectively. In an earlier phase III trial of 2,339 adults with obesity but no diabetes, published in September 2026, weekly doses of 4 mg, 9 mg and 12 mg led to average weight losses of 17.6%, 23.7% and 25.0%, against 3.9% with placebo. Its most commonly reported side effects are gastrointestinal, including nausea, vomiting and diarrhoea, and they become more frequent at higher doses.


Afghanistan reports six new wild polio cases, bringing its 2026 total to 42

Afghanistan has recorded six new cases of wild poliovirus type 1, bringing the country’s total for 2026 to 42, global health officials said ahead of World Polio Day. Three of the cases were in Kandahar district in Kandahar province, two in Nangarhar province, one each in the Batikot and Goshta districts, and one in Musayi district of Kabul province. The patients fell ill between 25 August and 9 September, and the Kabul case was identified through a positive contact.

Polio is a highly infectious disease that mainly affects children under five. The virus invades the nervous system and can cause paralysis or death, and there is no cure, so vaccination remains the most effective protection. Each dose given to a young child increases their protection, and repeated immunisation campaigns have shielded millions of children, allowing almost every country in the world to become free of the disease. Afghanistan and neighbouring Pakistan are the only two countries where wild polio remains endemic.

The global eradication effort began in 1988, led by the World Health Organization, Unicef and the Rotary Foundation, and has been driven through the Global Polio Eradication Initiative. Of the three wild strains, type 2 was certified eradicated in 2015, its last case having been found in 1999, and type 3, not detected since 2012, was certified eradicated in 2019. Type 1 is therefore the only wild strain still circulating, and in 2016 the trivalent oral vaccine was replaced by a bivalent version.


Alberta expands hospital capacity ahead of the respiratory virus season

The Canadian province of Alberta has expanded hospital capacity and launched new triage measures to prepare for rising demand during the respiratory virus season. The government said it has added more than 9,000 acute care spaces, with more than 221 hospital spaces now open, including 79 in Calgary and 102 in Edmonton, and another 194 temporary spaces that can be activated if demand exceeds existing capacity. Home care and hospital discharge programmes have also freed the equivalent of 175 acute care beds over the past year.

A new Triage Liaison Physician programme will place doctors directly in busy emergency department waiting areas to give patients an earlier point of contact, and hospitals are introducing automated daily staffing reports to show where more support is needed. Premier Danielle Smith said acute care capacity was at the highest level in the province’s history, while acknowledging that not every seasonal surge could be prevented. Acute Care Alberta will monitor capacity and patient flow, with set triggers guiding further measures.

Flu vaccination is free for all Albertans aged six months and older, and since 1 October eligibility for RSV immunisation has been extended to vulnerable adults aged 18 to 69 with certain serious conditions, such as transplant recipients and people on dialysis. Alberta Health Services, headquartered in Edmonton, is the largest integrated provincial health system in Canada and operates more than 1,000 facilities. In 2024 it began splitting into four separate agencies, and its board of directors was dissolved in January 2025.


San Francisco traces two active tuberculosis cases to a Market Street club

San Francisco’s public health department is investigating two confirmed active cases of tuberculosis associated with The Crazy Horse, a strip club at 980 Market Street in the Tenderloin district that has operated for more than three decades. The department said it was notified of the first case in early October and began contact tracing to find people who may have been exposed and to prevent further spread. It said the risk to the general public is low and that it would inform residents if that changed.

Tuberculosis bacteria are airborne and can linger in a room after an infected person has left, so crowded, poorly ventilated spaces carry a higher risk, said Abraar Karan, an infectious diseases specialist at Stanford. Peter Chin-Hong, a professor of medicine at UCSF, said tracing would continue for some time because the bacteria grow slowly and tests may need repeating, and that it is not yet clear whether both people were infected at the club. Last November, an outbreak at Archbishop Riordan High School in the city affected one in five students.

Tuberculosis is the leading cause of death from a single infectious agent worldwide. Most infections cause no symptoms and are described as latent, and people with latent tuberculosis do not spread the disease, but a small share progress to active illness that can be fatal if untreated, more often in people with weakened immune systems. An estimated one quarter of the world’s population, around 2 billion people, carry a latent infection. Prevention relies on screening high-risk groups, early detection and treatment, and the BCG vaccine.

In this topic